Efficacy and safety study of Esomeprazole vs Omeprazole to treat acute non-variceal upper gastrointestinal bleeding
Study identifier:D961DL00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A randomised, double-blind, double-dummy, active-controlled, multicenter study to assess the efficacy and safety of esomeprazole or omeprazole for 5 days in subjects with acute non-variceal upper gastrointestinal bleeding
Medical condition
Gastrointestinal Hemorrhage
Phase
Phase 3
Healthy volunteers
No
Study drug
Esomeprazole IV, Omeprazole IV
Sex
All
Actual Enrollment
440
Study type
Interventional
Age
18 Years - 65 Years
Date
Study Start Date: 01 Aug 2006
Primary Completion Date: -
Study Completion Date: 01 Oct 2007
Study design
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Tore Lind
AstraZeneca
